Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals is a research paper published in Cell Reports (2021). On theSindex it has a DataRank of 0. It has been cited 114 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Defense Advanced Research Projects Agency
Grant: AI083203
Defense Advanced Research Projects Agency
Grant: AI095202
Defense Advanced Research Projects Agency
Grant: R35 HL145242
Defense Advanced Research Projects Agency
Grant: AI157155
Defense Advanced Research Projects Agency
Grant: AI141707
Defense Advanced Research Projects Agency
Grant: HR0011-18-3-0001
Defense Advanced Research Projects Agency
Grant: AI12893
Defense Advanced Research Projects Agency
Grant: AI149928
Defense Advanced Research Projects Agency
Grant: AI150739
Defense Advanced Research Projects Agency
Grant: 75N93019C00073
Defense Advanced Research Projects Agency
Grant: HR0011-18-2-0001
Defense Advanced Research Projects Agency
Grant: AI130591
AstraZeneca
Grant: F30 AI152327
AstraZeneca
Grant: T32 AI138932
National Institutes of Health
Grant: UL1 TR001439
National Institutes of Health
Grant: DK103126
National Institutes of Health
Grant: GM136853
National Institutes of Health
Grant: 002196
National Institutes of Health
Grant: 75N93019C00062
National Institutes of Health
Grant: 75N93019C00074
NIAID NIH HHS
Grant: R01 AI141707
NIAID NIH HHS
Grant: T32 AI095202
NIAID NIH HHS
Grant: F30 AI149928
NIAID NIH HHS
Grant: U01 AI150739
NIGMS NIH HHS
Grant: R01 GM136853
NIAID NIH HHS
Grant: T32 AI083203
NIDDK NIH HHS
Grant: R00 DK103126
NIAID NIH HHS
Grant: R01 AI130591
NIAID NIH HHS
Grant: R01 AI157155
NIDDK NIH HHS
Grant: K99 DK103126
NCI NIH HHS
Grant: T32 CA009213
NCI NIH HHS
Grant: R41 CA271967
National Institutes of Health
Grant: 1F30AI152327-01A1
Regulation of Antiviral Responses in Plasmacytoid Dendritic Cells to Chikungunya Virus by the Gut Microbiota
National Institutes of Health
Grant: 5F30AI149928-02
Complete mapping of the functional and antigenic effects of mutations to Lassa virus glycoprotein
National Institutes of Health
Grant: 5T32AI138932-03
Immunological Mechanisms of Disease Training Program
National Institutes of Health
Grant: 5U01AI150739-05
Structure based design of trimer interface epitope focused universal influenza vaccines
National Institutes of Health
Grant: 5R01AI157155-02
Human antibody-based countermeasures against the Coronavirus SARS-CoV-2
National Institutes of Health
Grant: 5R35HL145242-02
Defining and Controlling Airway Disease
National Institutes of Health
Grant: 5R01AI141707-02
Prospectively characterizing the functional and antigenic effects of mutations to viral entry proteins
National Institutes of Health
Grant: 5UL1TR001439-07
UTMB Clinical and Translational Science Award
National Institutes of Health
Grant: 5R01AI130591-02
PARP9-DTX3L Control Of Viral Infection and Airway Disease
Merck KGaA
Vanderbilt University
Takeda Pharmaceutical Company
University of Arizona
George Mason University
Takeda Pharmaceuticals U.S.A.
University of Edinburgh
FWCI
5.20
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals